• Home
  • BREAST CANCER
  • GASTOINTESTINAL CANCERS
    • GASTRIC CANCER
    • COLON CANCER
    • RECTAL CANCER
    • PANCREATIC CANCER
  • GYNAECOLOGICAL CANCERS
    • UTERINE CANCER
    • OVARIAN CANCER
    • CERVICAL CANCER
  • OTHER CANCERS
    • HEAD AND NECK CANCERS
    • SOFT TISSUE SARCOMA
  • BOOK APPOINTMENT
  • More
    • Home
    • BREAST CANCER
    • GASTOINTESTINAL CANCERS
      • GASTRIC CANCER
      • COLON CANCER
      • RECTAL CANCER
      • PANCREATIC CANCER
    • GYNAECOLOGICAL CANCERS
      • UTERINE CANCER
      • OVARIAN CANCER
      • CERVICAL CANCER
    • OTHER CANCERS
      • HEAD AND NECK CANCERS
      • SOFT TISSUE SARCOMA
    • BOOK APPOINTMENT
  • Home
  • BREAST CANCER
  • GASTOINTESTINAL CANCERS
    • GASTRIC CANCER
    • COLON CANCER
    • RECTAL CANCER
    • PANCREATIC CANCER
  • GYNAECOLOGICAL CANCERS
    • UTERINE CANCER
    • OVARIAN CANCER
    • CERVICAL CANCER
  • OTHER CANCERS
    • HEAD AND NECK CANCERS
    • SOFT TISSUE SARCOMA
  • BOOK APPOINTMENT

Dr. RAHUL REDDY LEVAKA

Dr. RAHUL REDDY LEVAKADr. RAHUL REDDY LEVAKADr. RAHUL REDDY LEVAKA

Everything you need to know about Colon Cancer

How common is colon cancer?

Globally, colorectal cancer (CRC) ranks third in incidence and second in mortality. In is the most commonly diagnosed Gastro Intestinal cancer worldwide, with 1.8 million new cases and 881,000 deaths. Among men, it ranks third in incidence and fourth in mortality, while among women, it ranks second in incidence and third in mortality. Higher Human Development Index countries exhibit up to 3-fold higher CRC incidence rates, with most literature originating from high-income countries. Low- and middle-income countries report a relatively lower burden of CRC, with India reporting age-standardized incidence rates of 7.2 and 5.1 per 100,000 population for men and women, respectively, compared to global rates of 20.6 and 14.3 per 100,000 population. However, India faces higher CRC mortality rates due to limited screening, healthcare access, and advanced stage at presentation. Recent epidemiological research indicates a rising incidence of CRC in India due to demographic and economic shifts, evolving lifestyles, and dietary changes.

Risk factors for colon and rectal cancers

Age and Gender

  • Age: The risk of colon and rectal cancers increases significantly after the age of 50. Most cases are diagnosed in individuals aged 60 and older.
  • Gender: Both men and women are at risk, but men have a slightly higher incidence rate compared to women.

Family History and Genetic Factors

  • Family History: A family history of colorectal cancer or polyps increases risk. This is particularly true if a first-degree relative (parent, sibling, or child) has had the disease.
  • Genetic Syndromes: Inherited conditions such as Familial Adenomatous Polyposis (FAP) and Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer or HNPCC) significantly increase the risk. Individuals with these syndromes often develop colorectal cancer at a younger age and may have multiple cancers.

DIET

  • Red and Processed Meats: High consumption of red meat (e.g., beef, pork) and processed meats (e.g., bacon, sausages) has been associated with an increased risk of colorectal cancer. These meats may contain carcinogenic compounds formed during cooking or processing.
  • Low Fiber Intake: Diets low in dietary fiber, commonly found in fruits, vegetables, and whole grains, may increase risk. Fiber helps in maintaining regular bowel movements and may protect against cancer by producing beneficial compounds during digestion.
  • Calcium and Vitamin D: Adequate intake of calcium and vitamin D may offer some protective effects against colorectal cancer. They are believed to play a role in regulating cell growth and differentiation.

Lifestyle Factors:

  • Smoking: Tobacco use is a known risk factor for various cancers, including colorectal cancer. The carcinogens in tobacco can contribute to cancer development in the colon and rectum.
  • Alcohol Consumption: Heavy and prolonged alcohol use is associated with an increased risk of colorectal cancer. Alcohol can act as a carcinogen, affect nutrient absorption, and contribute to liver disease, which may further impact cancer risk

Lifestyle Factors:

  • Physical Activity: Regular physical activity is associated with a reduced risk of colorectal cancer. Exercise helps maintain a healthy weight and can positively influence gut motility and immune function.
  • Obesity: Excess body weight, particularly abdominal obesity, is linked to a higher risk of colorectal cancer. Obesity can lead to chronic inflammation and insulin resistance, which are factors associated with cancer development.

Medical History:

  • Previous Colorectal Polyps: Having a history of adenomatous polyps or other colorectal polyps increases the likelihood of developing colorectal cancer.
  • Inflammatory Bowel Disease (IBD): Chronic inflammatory conditions like ulcerative colitis and Crohn's disease can elevate risk, particularly after years of persistent inflammation.

Symptoms of colon cancer


1. Changes in Bowel Habits

  • Persistent diarrhea or constipation, or noticeable changes in stool consistency, which may be due to the tumor affecting bowel function or causing partial obstruction.

2. Rectal Bleeding or Blood in Stool

  • Blood in the stool, which can be bright red or dark and tarry, often occurs when the tumor erodes blood vessels in the colon or rectum.

3. Abdominal Pain or Discomfort

  • Persistent or crampy abdominal pain related to tumor growth or bowel obstruction. The pain may be localized or generalized across the abdomen.

4. Unexplained Weight Loss

  • Significant weight loss without an obvious cause, which can result from increased energy expenditure, reduced appetite, or difficulties in nutrient absorption.

5. Fatigue or Weakness

  • Ongoing tiredness or weakness, often linked to anemia from chronic bleeding or the body’s response to cancer.

6. Feeling of Incomplete Bowel Movement

  • A sensation of not fully emptying the bowel after a movement, which can be caused by a tumor obstructing or narrowing the colon.

7. Nausea and Vomiting

  • These symptoms can arise if a tumor causes bowel obstruction or disrupts normal digestive processes.

8. Anemia

  • Low red blood cell count, leading to symptoms like pallor and shortness of breath, often resulting from chronic blood loss in the stool.

9. Abdominal Mass

  • A palpable lump or mass in the abdomen that may be felt in advanced cases where the tumor is sufficiently large.

10. Persistent Gas or Bloating

  • Excessive gas or bloating can occur due to tumor-induced changes in bowel function or obstruction, leading to gas and fluid accumulation


Emergency Presentation:


Bowel Obstruction in Colon Cancer

Bowel obstruction in colon cancer occurs when a tumor blocks the colon, preventing stool from passing. Symptoms typically include severe abdominal pain, cramping, inability to pass gas or have bowel movements, nausea, vomiting, and abdominal swelling. Diagnosis usually involves imaging techniques such as CT scans. Treatment often requires surgery to remove the obstruction, and may involve resection of the tumor or affected bowel segment, and possibly a temporary colostomy. If not addressed promptly, complications like bowel perforation and infection can arise. Early intervention is crucial to alleviate symptoms and prevent severe outcomes.



Tests done for colon cancer


Colonoscopy

  • Purpose: Visualizes the entire colon and rectum, allows for direct biopsy of suspicious lesions, and assesses the extent of the disease.


CT Scan (Computed Tomography)

  • Purpose: Evaluates the abdomen and pelvis to determine the size of the tumor, check for lymph node involvement, and detect distant metastases.


Ultrasound

  • Purpose: Assesses liver metastases and guides biopsies; less commonly used but can help evaluate other potential sites of metastasis.


Biopsy Analysis

  • Purpose: Confirms the diagnosis of colon cancer, determines the histological type and grade of the tumor through microscopic examination of tissue samples.


Blood Tests

  • Routine Blood Tests: Includes Complete Blood Count (CBC) to detect anemia and liver function tests to check for liver involvement.


Serum Marker


  • Carcinoembryonic Antigen (CEA): A blood test used to measure levels of CEA, a protein that may be elevated in individuals with colon cancer. It helps in monitoring the disease, assessing treatment response, and detecting recurrence.

Treatment For Colon Cancer

Surgery for colon cancer:

Surgery is a key treatment for colon cancer, focusing on removing the cancerous tumor and surrounding affected tissue. It is usually the main approach for localized colon cancer and may also be used for more advanced stages of the disease.


Types of Surgery:


  1. Colectomy: Involves removing a section of the colon containing the tumor. This can be a partial colectomy, where only a part of the colon is removed, or a total colectomy, where the entire colon is taken out, depending on the tumor’s location and extent.
  2. Hemicolectomy: Removes half of the colon, typically performed for tumors located in the right or left side of the colon. It involves resection of the affected segment along with nearby lymph nodes.
  3. Segmental Resection: Targets a specific segment of the colon where the cancer is confined. The removed segment is usually replaced by joining the healthy ends of the bowel.
  4. Laparoscopic Surgery: A minimally invasive procedure using small incisions, specialized instruments, and a camera to remove the tumor. This approach often results in a quicker recovery and less postoperative pain compared to traditional open surgery.
  5. Colostomy: Creates an opening (stoma) in the abdomen for waste to exit the body when part or all of the colon is removed. This can be temporary or permanent based on the extent of the surgery and the need for bowel healing.

Additional Treatments

Adjuvant treatment for colon cancer is administered after surgery to lower the risk of cancer recurrence.

  1. Chemotherapy: Often given to eliminate any remaining cancer cells and reduce recurrence risk. Common regimens include combinations of drugs like fluorouracil (5-FU) and oxaliplatin (FOLFOX or CapeOX).
  2. Targeted Therapy: Used to specifically attack cancer cells based on genetic markers or pathways. This includes anti-VEGF drugs (e.g., bevacizumab) and anti-EGFR drugs (e.g., cetuximab).
  3. Immunotherapy: Boosts the immune system to target cancer cells, used in specific cases with genetic mutations such as high microsatellite instability (MSI-H).


Copyright © 2025 Dr. RAHUL REDDY LEVAKA - All Rights Reserved.

  • BOOK APPOINTMENT

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept